StatLab Medical Products Acquires Especialidades Médicas Myr (Myr)

Leica Biosystems Acquires StatLab Medical Products

September 28, 2026

Medical Devices

Leica Biosystems, a Danaher company, completed its acquisition of StatLab Medical Products from Linden Capital Partners and Audax Private Equity on September 28, 2026. StatLab’s pre-analytical pathology consumables and equipment add specimen collection and preparation capabilities to Leica Biosystems’ pathology portfolio, broadening its offering from specimen collection through digital imaging and AI-enabled diagnosis.

Leica Biosystems to Acquire StatLab Medical Products From Linden Capital Partners and Audax Private Equity

July 14, 2026

Medical Devices

Leica Biosystems, a Danaher company, signed a definitive agreement to acquire StatLab Medical Products. StatLab is currently owned by Linden Capital Partners and Audax Private Equity, and the transaction is subject to customary closing conditions. Financial terms were not disclosed and the deal was expected to close by the end of 2026.

StatLab Acquires Histoserve GmbH and Remaining Stake in Diapath France SAS

August 13, 2025

Medical Devices

StatLab Medical Products completed the acquisitions of Germany-based Histoserve GmbH and the remaining stake in Diapath France SAS, bringing both businesses into the Diapath/StatLab European organization. The transactions expand StatLab’s direct commercial presence across the four largest European pathology markets (France, Germany, Italy and the UK) and strengthen service, distribution and equipment capabilities for pathology laboratories in those markets.

StatLab Medical Products Acquires Scientific Device Laboratory

April 25, 2024

Medical Devices

StatLab Medical Products, a McKinney, Texas-based manufacturer of medical diagnostic supplies, has acquired Scientific Device Laboratory (SDL), a Chicago-area maker of printed diagnostic slides and consumables for anatomic pathology and microbiology. The acquisition expands StatLab's microbiology capabilities, adds a U.S. R&D/manufacturing hub, and creates a dual-continent footprint for glass-slide manufacturing to better serve hospital, OEM and research customers.

StatLab Medical Products Acquires Poly Scientific R&D

March 26, 2024

Medical Devices

StatLab Medical Products has acquired Poly Scientific R&D, a Bay Shore, New York-based manufacturer of pathology stains, reagents and tissue controls. The deal adds tissue control slide manufacturing and other anatomic pathology consumables to StatLab’s portfolio, expanding its manufacturing capabilities and market presence.

Audax Private Equity and Linden Capital Partners Acquire StatLab Medical Products

January 12, 2021

Medical Devices

Audax Private Equity and Linden Capital Partners have acquired StatLab Medical Products, a McKinney, Texas-based manufacturer and distributor of histology, cytology and immunohistochemistry consumables, reagents, and equipment. The deal — a purchase from Cressey & Company LP — positions StatLab for accelerated organic growth and buy-and-build activity to expand its product suite and customer base.